Profhilo is an injectable skin treatment made from highly purified hyaluronic acid (HA). Its not a traditional filler that adds volume. Instead its designed to hydrate, stimulate collagen and elastin production, and remodel skin quality from within. HA attracts and holds water which plumps and hydrates tissue while triggering fibroblasts to make new collagen and elastin. This gives a gradual improvement in skin firmness, elasticity, and texture.
Our dataset currently has 5 clinic(s), with approximately 349 reviews and an average rating of 4.5.
Medical Infrastructure:
- Lancashire Teaching Hospitals NHS Foundation Trust (Royal Preston Hospital)
- Established dermatology and skin cancer services
- Multiple GP training practices.
Local Aethetics Market:
Mid-stage with consultant-led dermatology integration and established injectables market.
Profhilo itself has regulatory approvals (MHRA and FDA reported in some sources) confirming it's safety profile as an injectable HA treatment. However specific NICE procedural guidance may be limited, and UK practice of cosmetic injectables lacks strict regulation on who can provide treatments, so clinician judgement and adherence to best practices matter.
Local regulatory authority:
Care Quality Commission (CQC) for regulated healthcare activities in England.
Private insurance usage locally:
- Medical dermatology (e.g., skin cancer, basal cell carcinoma) may be covered by private insurers
- Cosmetic injectables predominantly self-funded.
Cosmetic finance availability:
- Available for higher-value procedures
- Structured finance more common in Manchester corridor but accessible locally.
Current average rating citywide: 4.5